Katsuhisa Suzuki

Title: Katsuhisa Suzuki: Innovator in Antibody Development

Introduction

Katsuhisa Suzuki is a prominent inventor based in Tsukubamirai, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 2 patents to his name, his work has the potential to impact therapeutic approaches in medicine.

Latest Patents

One of his latest patents involves an anti-human Notch4 antibody. This invention provides an anti-human Notch4 antibody or a Notch4 binding fragment that may exhibit neutralizing activity against human Notch4. The patent details a pharmaceutical composition that includes this antibody as the active ingredient. The inventors, including Suzuki, successfully obtained a mouse anti-human Notch4 antibody with high neutralizing activity and binding affinity towards human Notch4. They determined the complementarity determining region (CDR) sequence of this antibody, which facilitated the production of a humanized antibody that incorporates the variable region of heavy and light chains along with the CDR sequence.

Career Highlights

Katsuhisa Suzuki is associated with Eisai R&D Management Co., Ltd., where he continues to advance his research in antibody development. His work is characterized by a commitment to innovation and excellence in the field of biotechnology.

Collaborations

He has collaborated with notable coworkers, including Masahiko Katayama and Yoshimasa Sakamoto. These partnerships have contributed to the successful development of his patented technologies.

Conclusion

Katsuhisa Suzuki is a key figure in the field of antibody research, with a focus on developing innovative solutions for medical applications. His contributions are paving the way for advancements in therapeutic treatments.